'Nilotinib 150' presentation slideshows

Potential of Nilotinib to Modulate Dopamine in Parkinson

According to the Phase 2 of clinical trial, Nilotinib (Brand Tasigna) manufactured by Novartis can help in modulating the metabolism and level of dopamine in the body. Formation of toxic-alpha synuclein aggregates can also be prevented with the help Nilotinib (generic of Tasigna) treatment. Source: https://www.cancercurepharmacy.com/BlogDetails.aspx?Title=Potential-of-Nilotinib-to-Modulate-Dopamine-in-Parkinsons

41 views • 3 slides